Class information for:
Level 1: HYDROXYCHLOROQUINE//PLAQUENIL//CHLOROQUINE ADVERSE EFFECTS

Basic class information
ID Publications Average number
of references		 Avg. shr. active
ref. in WoS
16609 579 29.2 59%


Bar chart of Publication_year

Last years might be incomplete

Classes in level above (level 2)


ID, lev.
above		 Publications Label for level above
1442 7319 MYASTHENIA GRAVIS//AGRIN//ACETYLCHOLINE RECEPTORS

Terms with highest relevance score


Rank Term Type of term Relevance score
(tfidf)		 Class's shr.
of term's tot.
occurrences		 Shr. of publ.
in class containing
term		 Num. of
publ. in
class
1 HYDROXYCHLOROQUINE Author keyword 22 21% 16% 92
2 PLAQUENIL Author keyword 9 64% 2% 9
3 CHLOROQUINE ADVERSE EFFECTS Author keyword 8 100% 1% 5
4 HYDROXYCHLOROQUINE TOXICITY Author keyword 6 80% 1% 4
5 HYDROXYCHLOROQUINE RETINOPATHY Author keyword 6 100% 1% 4
6 TOXIC MACULOPATHY Author keyword 6 100% 1% 4
7 CHLOROQUINE TOXICITY Author keyword 4 75% 1% 3
8 HEART CONDUCTION DISORDERS Author keyword 4 75% 1% 3
9 CHLOROQUINE MACULOPATHY Author keyword 3 100% 1% 3
10 NEUROMYOTOXICITY Author keyword 3 100% 1% 3

Web of Science journal categories

Author Key Words


Rank Web of Science journal category Relevance score
(tfidf)		 Class's shr.
of term's tot.
occurrences		 Shr. of publ.
in class containing
term		 Num. of
publ. in
class		 LCSH search Wikipedia search
1 HYDROXYCHLOROQUINE 22 21% 16% 92 Search HYDROXYCHLOROQUINE Search HYDROXYCHLOROQUINE
2 PLAQUENIL 9 64% 2% 9 Search PLAQUENIL Search PLAQUENIL
3 CHLOROQUINE ADVERSE EFFECTS 8 100% 1% 5 Search CHLOROQUINE+ADVERSE+EFFECTS Search CHLOROQUINE+ADVERSE+EFFECTS
4 HYDROXYCHLOROQUINE TOXICITY 6 80% 1% 4 Search HYDROXYCHLOROQUINE+TOXICITY Search HYDROXYCHLOROQUINE+TOXICITY
5 HYDROXYCHLOROQUINE RETINOPATHY 6 100% 1% 4 Search HYDROXYCHLOROQUINE+RETINOPATHY Search HYDROXYCHLOROQUINE+RETINOPATHY
6 TOXIC MACULOPATHY 6 100% 1% 4 Search TOXIC+MACULOPATHY Search TOXIC+MACULOPATHY
7 CHLOROQUINE TOXICITY 4 75% 1% 3 Search CHLOROQUINE+TOXICITY Search CHLOROQUINE+TOXICITY
8 HEART CONDUCTION DISORDERS 4 75% 1% 3 Search HEART+CONDUCTION+DISORDERS Search HEART+CONDUCTION+DISORDERS
9 CHLOROQUINE MACULOPATHY 3 100% 1% 3 Search CHLOROQUINE+MACULOPATHY Search CHLOROQUINE+MACULOPATHY
10 NEUROMYOTOXICITY 3 100% 1% 3 Search NEUROMYOTOXICITY Search NEUROMYOTOXICITY

Key Words Plus


Rank Web of Science journal category Relevance score
(tfidf)		 Class's shr.
of term's tot.
occurrences		 Shr. of publ.
in class containing
term		 Num. of
publ. in
class
1 CHLOROQUINE RETINOPATHY 57 78% 7% 38
2 RETINAL TOXICITY 29 33% 12% 72
3 HYDROXYCHLOROQUINE RETINOPATHY 23 60% 4% 25
4 EARLY CHLOROQUINE RETINOPATHY 15 82% 2% 9
5 CHLOROQUINE HYDROXYCHLOROQUINE 14 100% 1% 7
6 HYDROXYCHLOROQUINE 11 12% 14% 79
7 LONG TERM HYDROXYCHLOROQUINE 8 100% 1% 5
8 OPHTHALMOLOGIC SAFETY 6 80% 1% 4
9 OCULAR SAFETY 6 44% 2% 11
10 MULTIFOCAL ELECTRORETINOGRAPHY 5 28% 2% 14

Journals

Reviews


Title Publ. year Cit. Active references % act. ref.
to same field
Clinical efficacy and side effects of antimalarials in systemic lupus erythematosus: a systematic review 2010 184 83 30%
Chloroquine cardiomyopathy - a review of the literature 2013 9 63 84%
Hydrochloroquine retinopathy: characteristic presentation with review of screening 2013 6 6 83%
Hydroxychloroquine cardiotoxicity in systemic lupus erythematosus: A report of 2 cases and review of the literature 2004 41 60 73%
Ocular toxicity due to chloroquine and hydroxychloroquine: electrophysiological and visual function correlates 2005 17 55 73%
Hydroxychloroquine: From Malaria to Autoimmunity 2012 46 89 20%
Re-evaluation of antimalarials in treating rheumatic diseases: re-appreciation and insights into new mechanisms of action 2011 31 16 44%
The role of antimalarial agents in the treatment of SLE and lupus nephritis 2011 43 107 35%
ANTIMALARIAL AGENTS AND LUPUS 1994 95 52 38%
New concepts in antimalarial use and mode of action in dermatology 2007 73 128 23%

Address terms


Rank Address term Relevance score
(tfidf)		 Class's shr.
of term's tot.
occurrences		 Shr. of publ.
in class containing
term		 Num. of
publ.
in class
1 REDWOOD CITY MED 2 50% 0.5% 3
2 UNIT RENAL INFECT DIS 2 25% 1.0% 6
3 BYERS EYE 1 17% 1.2% 7
4 INSERMU483 1 40% 0.3% 2
5 UNITE ELE OPHYSIOL 1 40% 0.3% 2
6 ANAT PHYSIOL MED 1 50% 0.2% 1
7 ANKARA ATATURK EDUC TRAINING HOSP 1 50% 0.2% 1
8 EXPLORAT FONCTIONELLES NEUROL 1 50% 0.2% 1
9 EXPLORAT FONCTIONNELLE VIS 1 50% 0.2% 1
10 MANISA DEVLET HASTANESI 1 50% 0.2% 1

Related classes at same level (level 1)


Rank Relatedness score Related classes
1 0.0000178930 DS DNA ANTIBODIES//INTERNAL AUTOIMMUNE METAB DIS//CHU PITIE SALPETRIERE HP
2 0.0000162652 HALOFANTRINE//3 HYDROXYQUININE//QUININE
3 0.0000147946 4 FLUOROPYRIMIDINES//BE CYCLES//ELE OCHEM ENERGET
4 0.0000098678 CUTANEOUS LUPUS ERYTHEMATOSUS//DISCOID LUPUS ERYTHEMATOSUS//SUBACUTE CUTANEOUS LUPUS ERYTHEMATOSUS
5 0.0000090054 BLACK THYROID//BLACK HAIRY TONGUE//CHRYSIASIS
6 0.0000083610 PHOSPHOLIPIDOSIS//DRUG INDUCED PHOSPHOLIPIDOSIS//CATIONIC AMPHIPHILIC DRUGS
7 0.0000077387 MOTHERS RHEUMAT DIS//PREGNANCY RHEUMAT DIS//LUPUS PREGNANCY
8 0.0000071164 PALINDROMIC RHEUMATISM//RECURRENT ARTHRITIS//INTERMITTENT HYDRARTHROSIS
9 0.0000070724 PREFERENTIAL HYPERACUITY PERIMETRY//AMSLER GRID//POTENTIAL ACUITY METER
10 0.0000064540 METHOTREXATE//METHOTREXATE POLYGLUTAMATES//MX 68